S22-275 Composition and Method of Universal Programmable Virus-like Particles (VLPs) Stanford researchers have engineered retroviral and virus-like delivery systems for producing universal pseudotyped vehicles for cell and gene therapies. Lei Qi Michael Chavez Paul Finn
S23-091 Small-molecule control of membrane and secreted proteins via human proteases Researchers at Stanford have created a translational platform capable of controlling protein activity in cellular therapeutics using a human protease. Xiaojing Gao Carlos Aldrete